PNC Financial Services Group
AVIR icon

PNC Financial Services Group’s Atea Pharmaceuticals AVIR Stock Holding History

PNC Financial Services Group’s Portfolio AVIR Stock Details AVIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.9K Sell
2,785
-291
-9% -$1.45K ﹤0.01% 3975
2026
Q1 		$16.5K Buy
3,076
+231
+8% +$1.06K ﹤0.01% 3769
2025
Q4 		$10.2K Sell
2,845
-906
-24% -$2.88K ﹤0.01% 3940
2025
Q3 		$10.9K Sell
3,751
-543
-13% -$1.85K ﹤0.01% 3903
2025
Q2 		$15.5K Buy
4,294
+3,402
+381% +$10.1K ﹤0.01% 3687
2025
Q1 		$2.67K Buy
892
+843
+1,720% +$2.63K ﹤0.01% 4266
2024
Q4 		$164 Sell
49
-1,467
-97% -$4.88K ﹤0.01% 4666
2024
Q3 		$5.08K Buy
1,516
+1,260
+492% +$4.57K ﹤0.01% 4034
2024
Q2 		$847 Buy
256
+157
+159% +$585 ﹤0.01% 4460
2024
Q1 		$400 Buy
99
+25
+34% +$98 ﹤0.01% 4523
2023
Q4 		$226 Buy
+74
New +$224 ﹤0.01% 4478
2022
Q4 		– Sell
-5,000
Closed -$28K – 4763
2022
Q3 		$28K Hold
5,000
– – ﹤0.01% 3275
2022
Q2 		$36K Hold
5,000
– – ﹤0.01% 3176
2022
Q1 		$36K Sell
5,000
-132,050
-96% -$897K ﹤0.01% 3278
2021
Q4 		$1.23M Buy
137,050
+132,050
+2,641% +$2.06M ﹤0.01% 1173
2021
Q3 		$175K Hold
5,000
– – ﹤0.01% 2280
2021
Q2 		$107K Hold
5,000
– – ﹤0.01% 2614
2021
Q1 		$309K Hold
5,000
– – ﹤0.01% 1888
2020
Q4 		$209K Buy
+5,000
New +$161K ﹤0.01% 2044

Other funds holding AVIR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

PNC Financial Services Group's AVIR Position: Q2 2026 in Review

PNC Financial Services Group reduced its Atea Pharmaceuticals (AVIR) stake by 9.5% in Q2 2026, selling an estimated $1.45K and leaving 2,785 shares worth $12.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3975.

PNC Financial Services Group first reported a position in AVIR in Q4 2020 and has held it in 19 quarters since. The position peaked at $1.23M in Q4 2021. 124 funds tracked by Wall St. Rank hold AVIR as of Q2 2026.

  • PNC Financial Services Group held 2,785 shares of Atea Pharmaceuticals worth $12.9K as of Q2 2026.
  • PNC Financial Services Group sold 291 Atea Pharmaceuticals shares in Q2 2026, an estimated $1.45K.
  • Atea Pharmaceuticals made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #3975 holding.
  • PNC Financial Services Group first reported a position in Atea Pharmaceuticals in Q4 2020 and has held it in 19 quarters since.
  • PNC Financial Services Group's Atea Pharmaceuticals position peaked at $1.23M in Q4 2021.
  • 124 funds tracked by Wall St. Rank held Atea Pharmaceuticals as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.